Alpha-1-antichymotrypsin is not associated with the increased frequency of apolipoprotein-E-epsilon-4 allele in elderly non-demented leprosy patients

Dementia and Geriatric Cognitive Disorders

Volumn 9, Issue 1, 1998, Pages 26-28

  Endoh, Masumi ^a,b   Ueki, Akira ^c   Takahashi, Keikichi ^a   Yamanaka, Hideki ^a   Izumi, Shinzo ^b   Tabira, Takeshi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

1 antichymotrypsin; Alzheimer's disease; Apolipoprotein E; Dementia; Leprosy

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HUMAN; HUMAN CELL; LEPROSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENILE DEMENTIA;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ALPHA 1-ANTICHYMOTRYPSIN; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; FEMALE; GENOTYPE; HUMANS; LEPROSY; MALE; MIDDLE AGED;

EID: 0031983167     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017018     Document Type: Article

References (11)

1. McGeer PL, Harada N, Kimura H, McGeer EG, Schulzer M: Prevalence of dementia amongst elderly Japanese with leprosy: Apparent effect of chronic drug therapy. Dementia 1992;3:146-149.
2. Namba Y, Kawatsu K, Izumi S, Ueki A, Ikeda K: Neurofibrillary tangles and senile plaques in brain of elderly leprosy patients. Lancet 1992; 340:978.
3. Chui D-H, Tabira T, Izumi S, Koya G, Ogata J: Decreased β-amyloid and increased abnormal tau deposition in the brain of aged patients with leprosy. Am J Pathol 1994;145:771-775.
4. Roses AD: Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 1996;47:387-400.
5. Endoh M, Ueki A, Takahashi K, Yamanaka Y, Izumi S, Tabira T: Significantly increased frequency of apolipoprotein E ε4 allele in elderly non-demented leprosy patients. Neurosci Lett 1996;207:206-208.
6. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST: APOE*4-associated Alzheimer's disease risk is modified by al-antichymotryp-sin polymorphism. Nat Genet 1995;10:486-488.
7. Otsuka T, Shimonaka Y, Maruyama S, Nakazato K, Kitamura T, Yaguchi K, Sato S, Ikeda H: A new screening test for dementia. Jpn J Psychiatry Neurol 1988;42:223-229.
8. Haines JL, Pritchard ML, Saunders AM, Schildkraut JM, Growdon JH, Gaskell PC, Farrer LA, Auerbach SA, Gusella JF, Locke PA, Rosi BL, Yamaoka L, Small GW, Conneally PM, Roses AD, Pericak-Vance MA: No genetic effect of alphal-antichymotrypsin in Alzheimer disease. Genomics 1996;33:53-56.
9. Lilius L, Corder E, Basun H, Vitanen M, Winblad B, Lannfelt L: α1-Antichymotrypsin is not a susceptibility gene for Alzheimer's disease in old Swedes. Neurobiol Aging 1996(suppl 17): S59.
10. Nacmias B, Tedde A, Latorraca S, Forleo P, Piacentini S, Sorbi S, Amaducci L: Apolipoprotein E and α1 -antichymotrypsin polymorphism in Italian Alzheimer's disease. Neurobiol Aging 1996(suppl 17):S58.
11. Ueki A, Otsuka M, Ikeda K: α1-Antichymotrypsin genotypes modulate the risk of Alzheimer's disease associated with apolipoprotein E-ε4 allele. Neurobiol Aging 1996(suppl 17):S126.